Mass General Brigham Health Plan policy updates
Track new and updated Mass General Brigham Health Plan policies impacting reimbursement and clinical operations.
| Policy | Payer | Type | Specialty | Change | Effective |
|---|---|---|---|---|---|
| T-Cell Lymphoma Agents: Beleodaq, Istodax, Lymphir, Poteligeo, and Romidepsin | Mass General Brigham Health Plan | Clinical | Hematology/Oncology | Modified | Jan 4, 2027 |
| Calcitonin Gene-Related Peptide (CGRP) Inhibitors: Vyepti (eptinezumab-jjmr) | Mass General Brigham Health Plan | Clinical | Neurology/Neurosurgery | Modified | Jan 4, 2027 |
| Glaucoma Agents iDose TR (travoprost intracameral implant) | Mass General Brigham Health Plan | Clinical | Ophthalmology/Optometry | Modified | Jan 4, 2027 |
| Enzyme and Metabolic Disorder Therapies: Avlayah (tividenofusp alfa-eknm) | Mass General Brigham Health Plan | Clinical | Pharmacy & Specialty Drugs | Modified | Jan 4, 2027 |
| Neuromuscular Blockers: Botox, Daxxify, Dysport, Myobloc, and Xeomin | Mass General Brigham Health Plan | Clinical | Pharmacy & Specialty Drugs | Modified | Jan 4, 2027 |
| Enzyme and Metabolic Disorder Therapies: Adzynma (ADAMTS13, recombinant-krhn) | Mass General Brigham Health Plan | Clinical | Pharmacy & Specialty Drugs | Modified | Jan 4, 2027 |
| Anti-Retroviral Agents: Sunlenca (lenacapavir) and Trogarzo (ibalizumab-uiyk) | Mass General Brigham Health Plan | Clinical | Pharmacy & Specialty Drugs | Modified | Jan 4, 2027 |
| Colony-Stimulating Factors | Mass General Brigham Health Plan | Clinical | Pharmacy & Specialty Drugs | Modified | Jan 4, 2027 |
| Osteoporosis Agents: Xgeva (denosumab) and Denosumab Biosimilars | Mass General Brigham Health Plan | Clinical | Pharmacy & Specialty Drugs | Modified | Jan 4, 2027 |
| Treatment of Osteoporosis | Mass General Brigham Health Plan | Clinical | Pharmacy & Specialty Drugs | Modified | Jan 4, 2027 |
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.
OpenPayer by Trek Health — Policy intelligence for billing and revenue cycle teams.
Coverage data is sourced from publicly available payer medical policy documents and updated as payers publish revisions. Read more about where our data comes from. Always consult the primary payer source for clinical decision-making.